The potential role of calcitonin gene-related peptide (CGRP) in breast carcinogenesis and its correlation with 99mTc-(V)DMSA scintimammography

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 420-427

  Papantoniou, Vassilios ^a   Tsiouris, Spyridon ^a   Sotiropoulou, Maria ^a   Valsamaki, Pipitsa ^a   Koutsikos, John ^a   Ptohis, Nikolaos ^a   Dimitrakakis, Constantine ^a   Sotiropoulou, Evaggelia ^a   Melissinou, Maria ^b   Nakopoulou, Lydia ^c   Antsaklis, Aris ^a   Zerva, Cherry ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b METROPOLITAN HOSPITAL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; SUCCIMER TC 99M;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST LESION; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CARCINOGENESIS; CARCINOMA IN SITU; CELL PROLIFERATION; CORRELATION ANALYSIS; DRUG UPTAKE; EPITHELIUM HYPERPLASIA; FEMALE; HISTOLOGY; HUMAN; IMAGING; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREOPERATIVE PERIOD; PREVALENCE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCINTIMAMMOGRAPHY; STAINING; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CALCITONIN GENE-RELATED PEPTIDE; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MAMMOGRAPHY; PILOT PROJECTS; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 34548383057     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3180337792     Document Type: Article

References (51)

1. Eriksson M, Lundeberg T, Uvnäs-Moberg K. Studies on cutaneous blood flow in the mammary gland of lactating rats. Acta Physiol Scand. 1996;158:1-6.
2. Traurig H, Papka RE, Saria A, et al. Substance P immunoreactivity in the rat mammary nipple and the effects of capsaicin treatment on lactation. Naunyn Schmiedebergs Arch Pharmacol. 1984;328:1-8.
3. Heldin CH, Westermark B. Platelet-derived growth factor, mechanism of action and possible in vivo function. Cell Regul. 1990;1:555-566.
4. Thulesen J, Rasmussen TN, Schmidt P, et al. Calcitonin gene-related peptide (CGRP) in the nipple of the rat mammary gland. Histochemistry. 1994;102:437-444.
5. Weber CJ, O'Dorisio TM, McDonald TJ, et al. Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines. Surgery. 1989;106:1134-1139.
6. Amara SG, Jonas V, Rosenfeld MG, et al. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982;298:240-244.
7. Zochodne DW, Allison JA, Ho W, et al. Evidence for CGRP accumulation and activity in experimental neuromas. Am J Physiol. 1995;268:H584-H590.
8. Quirion R, Van Rossum D, Dumont Y, et al. Characterization of CGRP1 and CGRP2 receptor subtypes. Ann NY Acad Sci. 1992;657:88-105.
9. Raue F, Schneider HG, Zink A, et al. Action of calcitonin gene-related peptide at the calcitonin receptor of the T47D cell line. Horm Metab Res. 1987;19:563-564.
10. Hukkanen M, Konttinen YT, Santavirta S, et al. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience. 1993;54:969-979.
11. Madsen JE, Wang JS, Hukkanen M, et al. Sensory nerve ingrowth during bone graft incorporation in the rat. Acta Orthop Scand. 1996;67:217-220.
12. Manek S, Terenghi G, Shurey C, et al. Angiogenesis and reinnervation in skin flaps: the effects of ischaemia examined in an animal model. Int J Exp Pathol. 1994;75:243-255.
13. Jang YC, Isik FF, Gibran NS. Nerve distribution in hemangiomas depends on the proliferative state of the microvasculature. J Surg Res. 2000;93:144-148.
14. Schmid KW, Morgan JM, Baumert M, et al. Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B. Lab Invest. 1995;73:90-95.
15. Williams ED, Ponder BJ, Craig RK. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia. Clin Endocrinol (Oxf). 1987;27:107-114.
16. Mouri T, Takahashi K, Sone M, et al. Calcitonin gene-related peptide-like immunoreactivities in pheochromocytomas. Peptides. 1989;10:201-204.
17. Weber CJ, Kim D, Costanzo M, et al. Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+, K(+)-ATPase (NKA) inhibitory activity in human breast cyst fluid. Ann Surg Oncol. 1994;1:339-144.
18. 99mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res 2004;6:R56-62. Available at: http://breast-cancer-research. com/content/6/2/R56.
19. Papantoniou V, Tsiouris S, Mainta E, et al. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res 2005;7:R33-45. Available at: http://breast-cancer-research.com/content/7/1/R33.
20. 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging. 2005;32:820-827.
21. 99mTc-(V)DMSA uptake with cellular proliferation rate. Eur J Nucl Med Mol Imaging. 2005;32:1240-1241.
22. Papantoniou V, Tsiouris S, Koutsikos J, et al. Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy. Nucl Med Commun. 2006;27:911-917.
23. 99mTc-(V) -DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging. 2004;31:77-84.
24. 99mTc-(v)-DMSA. Eur J Cancer. 2006;42:1004-1013.
25. Cheng L, Khan M, Mudge AW. Calcitonin gene-related peptide promotes Schwann cell proliferation. J Cell Biol. 1995;129:789-796.
26. Papantoniou V, Ptohis N, Tsiouris S. Diffuse tracer uptake in scintimammography: not as nonspecific or benign as originally believed? J Nucl Med. 2006;47:554-555.
27. Thurfjell E, Lindgren A. Paraffin tissue block radiography of nonpalpable lesions with calcifications detected at mammography: 5-year consecutive series of surgically excised cases. Eur Radiol. 1997;7:1006-1009.
28. Elston CW, Ellis IO. Assessment of histological grade. In: Elston CW, Ellis IO, eds. The Breast. Edinburgh: Churchill Livingstone, 1998:365-384.
29. Symonds DA, Copeland BE, Drane A, et al. Pathologic correlation in mammographically directed breast biopsies. Arch Pathol Lab Med. 1992;116:28-32.
30. Brem SS, Gullino PM, Medina D. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science. 1977;195:880-882.
31. Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat. 1988;11:241-248.
32. Heffelfinger SC, Yassin R, Miller MA, et al. Vascularity of proliferative breast disease and carcinoma in situ correlates with histologic features. Clin Cancer Res. 1996;2:1873-1878.
33. Guidi AJ, Schnitt SJ, Fischer L, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 1997;80:1945-1953.
34. Rowe RW, Tomoda M, Strebel FR, et al. The natural progression of microvasculature in primary tumor and lymph node metastases in a breast carcinoma model: relationship between microvessel density, vascular endothelial growth factor expression, and metastatic invasion. Cancer Biol Ther. 2004;3:408-414.
35. Rivard A, Isner JM. Angiogenesis and vasculogenesis in treatment of cardiovascular disease. Mol Med. 1998;4:429-440.
36. Heffelfinger SC, Miller MA, Yassin R, et al. Angiogenic growth factors in preinvasive breast disease. Clin Cancer Res. 1999;5:2867-2876.
37. Dameron KM, Volpert OV, Tainsky MA, et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994;265:1582-1584.
38. Anan K, Morisaki T, Katano M, et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery. 1996;119:333-339.
39. de Jong JS, van Diest PJ, van der Valk P, et al. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer: II. Correlations with proliferation and angiogenesis. J Pathol. 1998;184:53-57.
40. Carvalho I, Milanezi F, Martins A, et al. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res 2005;7:R788-95. Available at: http://breast-cancer-research.com/content/7/5/R788.
41. Banerjee S, Sengupta K, Dhar K, et al. Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol Carcinog. 2006;45:871-880.
42. Rankin S, Rozengurt E. Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells: bell-shaped dose response and cross-talk with bombesin. J Biol Chem. 1994;269:704-710.
43. Abedi H, Dawes KE, Zachary I. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J Biol Chem. 1995;270:11367-11376.
44. Saito Y, Mori S, Yokote K, et al. Phosphatidylinositol 3-kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor. Biochem Biophys Res Commun. 1996;224:23-26.
45. Kakita A, Suzuki A, Nishiwaki K, et al. Stimulation of Na-dependent phosphate transport by platelet-derived growth factor in rat aortic smooth muscle cells. Atherosclerosis. 2004;174:17-24.
46. Bhardwaj B, Klassen J, Cossette N, et al. Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma. Clin Cancer Res. 1996;2:773-782.
47. Sueur S, Pesant M, Rochette L, et al. Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex. J Mol Cell Cardiol. 2005;39:955-963.
48. Blacklock AD, Smith PG. Estrogen increases calcitonin gene-related peptide-immunoreactive sensory innervation of rat mammary gland. J Neurobiol. 2004;59:192-204.
49. Erin N, Zhao W, Bylander J, et al. Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells. Breast Cancer Res Treat. 2006;99:351-364.
50. Legat FJ, Wolf P. Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin? Photochem Photobiol Sci. 2006;5:170-176.
51. Zudaire E, Martinez A, Cuttitta F. Adrenomedullin and cancer. Regul Pept. 2003;112:175-183.